Metoclopramide Tablet
NDC Package 48433-067-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Metoclopramide tablets are indicated for the:Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.Limitations of Use: Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [ see Use in Specific Populations ( 8.4) ]. This formulation utilizes a tablet delivery system. Marketed by Safecor Health Llc, this product is identified by NDC 48433-067 and is authorized under FDA application ANDA070184.

Identification & Billing

NDC Package Code
48433-067-20
Package Description
100 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK (48433-067-01)
Product Code
48433-067
11-Digit Billing Format
48433006720
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Metoclopramide
Non-Proprietary Name
Metoclopramide
Substance Name
Metoclopramide Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METOCLOPRAMIDE HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
Metoclopramide tablets are indicated for the:Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.Limitations of Use: Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [ see Use in Specific Populations ( 8.4) ].

Regulatory & Marketing

Labeler Name
Safecor Health Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA070184
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-03-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 48433-067-20 identifies a specific commercial package of 100 blister pack in 1 carton / 1 tablet in 1 blister pack (48433-067-01) of Metoclopramide, a human prescription drug labeled by Safecor Health Llc. This tablet is formulated for oral use and contains metoclopramide hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Safecor Health Llc on April 03, 2026. The current certification is valid through December 31, 2027.

How is this Safecor Health Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 48433006720. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
48433-067-20
11-Digit CMS (5-4-2)
48433-0067-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.